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Abstract
Mitochondria, cytoplasmic organelles originated from endosymbiotic 
bacteria, can be metaphorically described using “Janus bifrons” image, due 
to their involvement in life, providing cellular energy and resulting essential 
even for stem cells, but playing a key role also in cell death. Mitochondria own 
a maternally inherited genome and are the site of aerobic respiration; they can 
produce proteins, nucleotides, lipids, steroids and heme and result involved in 
iron homeostasis. Moreover, mitochondria can generate free radicals, break 
down waste products and represent the primary source of cellular heat. The 
size and shape of mitochondria depend on the intracellular metabolic status, 
from tubular presentation to a blob form in case of irreversible damage. Each 
mitochondrion carries different sets of DNA; when one set accumulates 
mutations, it can be replaced by another. It has been widely demonstrated 
that mitochondrial disorders are involved in many pathologies, including 
autism, multiple endocrinopathies, diabetes, Alzheimer’s disease, ataxia, 
Barth’s syndrome, myopathy, and even aging and cancer. Human population 
is characterized by different mitochondrial DNA haplogroups reflecting the 
mutations accumulated and useful to characterize genetic diversity. The 
mitochondrial role also results relevant in pregnancy, providing information 
about maternal-fetal dyad in physiological and in pathological conditions. 
Recent evidence suggests that an intriguing bidirectional inter-talk exists 
between microbiota and mitochondria, influencing cellular homeostasis 
and metabolism. A recently demonstrated mitochondrial property is the 
possibility to be transferred from a donor cell to a recipient cell, through a 
system of tunneling nanotubes. Recently, a promising integrated approach 
involving omics sophisticate technologies has been applied in mitochondrial 
pathophysiology. This is still at an early stage, and further studies will clarify 
such complex genotype-phenotype relationships. In conclusion, mitochondria 
are not simple energetic organelles but represent dynamic structures 
communicating with the cell nucleus and even with other cells, influencing 
metabolism and their targets’ functions. More detailed knowledge of their 
involvement in disease, even though a combined omics approach, could 
represent a chance for new therapies.
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Mitochondria: the way we were
The first report of mitochondria dates back to 
1840 [1]; subsequently Altmann, in 1890, defined 
them “bioblasts” [2] and finally Benda, in 1898, 
coined the name “mitochondria” [3]. This word 
derives from the Greek terms “mitos” (thread) and 
“chondros” (granule). Siekevitz, in 1957, named 
them “the powerhouse of the cell” [4] and Nass, in 
1963, discovered that mitochondria contain some 
DNA sequences [5]. Mitochondria can resemble 
a “Janus bifrons” image, due to their involvement 
in life, providing the cellular need for energy and 
therefore resulting essential even for stem cells 
(SCs). However, on the other side, they play a key 
role in two types of cell death: caspase-dependent 
apoptosis and caspase-independent intrinsic 
apoptosis [6]. 
A schematization of mitochondrial involvement 
in several physiological functions but also their 
involvement in various human diseases is provided 
in Fig. 1.
The “powerhouse of the cell” is multitasking: in 
fact, mitochondria are the site of aerobic respiration 
and supply the cells with the energetic coin 
Adenosine Triphosphate (ATP); moreover, they 
can produce chemical substances indispensable 
to the whole organism, including proteins, 
nucleotides, lipids, steroids and participate in the 
biosynthesis of heme too. These organelles result 
also involved in iron homeostasis and can generate 
free radicals, which are essential for physiological 
mechanisms but may also result deleterious, 
Figure 1. Schematization of mitochondrial involvement in several physiological functions and in diseases, since 
mitochondria can resemble a “Janus bifrons” image.
3/13
Journal of Pediatric and Neonatal Individualized Medicine • vol. 8 • n. 1 • 2019 www.jpnim.com Open Access
Once we were bacteria… mitochondria to infinity and beyond
since their overproduction, if not inactivated 
by endogenous enzymes, can lead to increased 
oxidative stress. In addition, mitochondria break 
down waste products and recycle some of them to 
save energy [7].
Mitochondrial ATP, reactive oxygen species 
(ROS) and reactive nitrogen species production 
is even crucial during intense exercise; therefore, 
several physiological modifications occur 
to face the increasing energy needs, such as 
new mitochondria biogenesis, ROS increased 
production and acute inflammatory responses [8].
Furthermore, mitochondria are the main source 
of cellular heat. According to the recent literature, 
they can act like thermostatic radiators, operating 
at temperature reaching 50 degrees Celsius, in 
order to maintain our body in a defined temperature 
range [9].
The pivotal role of mitochondrial proteins 
in energy production also makes them an ideal 
system for a rapid adaptation to a new climate or 
different dietary habits [10].
Mitochondrial disorders are involved in autism, 
multiple endocrinopathies, diabetes, dementia, 
Alzheimer’s disease, ataxia, Barth’s syndrome, 
myopathy and even in aging [11-14]. 
In 1967, Lynn Margulis (previously Lynn 
Sagan), as first, proposed that mitochondria 
originate from endosymbiotic bacteria [15]. This 
hypothesis had been previously formulated by 
others but was considered controversial by the 
scientific community, until modern phylogenomic 
analyses confirmed that their genome sequences 
were closely related to alphaproteobacteria, a class 
that encompasses Rickettsiales [16]. 
However, to highlight the great complexity 
of this debate and the still open issues, we also 
report a very recent study demonstrating that 
mitochondrial origins may be more ancient than 
those of alphaproteobacteria, since they could 
evolve from a proteobacterial lineage [17]. 
The symbiont bringing on mitochondria 
was probably a flagellate that, after having 
lost its autonomy, was retained in the cell 
because of its capacity to generate ATP. The 
proto-eukaryote cell managed the growth and 
division of the symbiont by sending proteins 
synthesized by cytosolic ribosomes and lipids 
transferred from the endoplasmic reticulum. In 
addition, the proto-eukaryote had to segregate the 
mitochondria into daughter cells during cellular 
division. In eukaryotic lineages, mitochondrial 
genome is reduced if compared to the ancestors’ 
alphaproteobacteria genome, since a thousand of 
genes were lost during the evolution. 
Mitochondria have their own genome, ma ter-
nally inherited. Mitochondrial DNA (mtDNA) 
is circular, double-stranded and composed by 
15,000-17,000 base pairs; it encodes 37 genes, of 
which 13 are for proteins, 22 are for tRNA, 2 are 
for rRNA. However, most of the proteins present 
in the mitochondria (approximately 1,500 in 
mammals) are coded by nuclear DNA [18].
The mitochondrial proteome is composed by 
1,100-1,900 distinct proteins, mostly encoded by 
the nuclear genome. Only 13 proteins are encoded 
by mitochondrial genome; they are involved in 
the respiratory chain. The majority of the proteins 
in human mitochondria, belonging to the “core 
mitochondrial proteins”, are stably present in the 
cell. One-third of mitochondrial proteins have a 
dual localization being present both inside and 
outside mitochondria. Mitochondrial proteins, 
such as cytochrome-c (which is involved in 
the caspase-dependent apoptosis), Caspase-
independent Apoptosis Inducing Factor and 
NADPH oxidase are usually released into the 
cytosol. Interestingly, the metabolic enzyme 
complex pyruvate dehydrogenase may be localized 
both in mitochondria and nucleus [19].
Some of these proteins also take part in critically 
important metabolic pathways, such as protein 
synthesis, amino acid and nucleotide metabolism, 
apoptosis [20].
Show me your shape… 
Mitochondria are pleomorphic organelles 
whose size and shape change depending on 
the intracellular metabolic status. It is possible 
to recognize a healthy cell by the shape of its 
mitochondria: in physiological conditions, 
mitochondria look tubular; in stressing but still 
reversible conditions they acquire a donut form, 
reaching a blob form when the occurred damage is 
irreversible [21].
They are constituted by two membranes, the 
inner one and the outer one, that include the matrix 
and the inter-membrane space, respectively. 
The mitochondrial matrix contains enzymes 
belonging to the fatty acid beta-oxidation and 
the Kreb’s cycle. Mitochondria are able to use 
molecules derived from nutrient uptakes, such 
as pyruvate and fatty acids, converting them to 
acetyl coenzyme A (CoA), which is involved in 
the citric acid cycle.
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MtDNA replication does not strictly depend on 
the cellular cycle [22].
Each mitochondrium carries numerous and 
different sets of DNA; this expression refers to the 
co-existing presence of several copies of mtDNA 
[23]. Each of them is predisposed to the production 
of the same proteins and therefore, when one 
set accumulates mutations, it is eliminated and 
replaced by another, compensating its loss. MtDNA 
is more susceptible to mutations and damage, due 
to the lack of the protection conferred by histones 
[24] and other reasons, such as high levels of 
ROS and a reduced DNA repair ability, somatic 
mtDNA mutations (primarily in the displacement 
loop, a non-coding sequence also called D-loop). 
Therefore, a high number of mutations occur in 
each individual mtDNA over time. It is also known 
that the majority of these variants are benign 
and related to single nucleotide polymorphisms 
(SNPs) in the nuclear genome. The frequencies of 
these variants and the differences showed differ 
among populations and have been used to perform 
haplogrouping studies [10]. 
In fact, it has been postulated that the human 
population can be characterized by different 
mtDNA haplogroups, according to SNPs belonging 
to the mitochondrial genome. This would reflect 
the mutations accumulated via maternal lineage. 
For their ancient origin, mtDNA variants represent 
ancestral roots from tens of thousands of years 
ago. They can help to understand the migrations 
occurred, the accumulation and transmission 
of characteristic sets over generations and the 
growing genetic diversity. In conclusion, in this 
perspective, haplogroups may be useful to evaluate 
genomic ancestry, can be considered ancestral 
tags and additional links with other nuclear DNA 
markers can also be found [10].
There is a continuous cross-talk between 
mtDNA and nuclear DNA. MtDNA transcription 
is controlled by the mitochondrial transcription 
factors A and B which are nuclear encoded. In 
addition, mtDNA transcription and replication are 
regulated by the mitochondrial D-loop [25].
Human mtDNA is composed of heavy and 
light strands. MtDNA copy number for each 
mitochondrion varies from one to more copies. All 
the copies of mitochondrial genome are similar; 
however, both mutations and cytosine methylation 
may occur. The term “heteroplasmy” refers to the 
co-existence of the wild-type and mutant mtDNA, 
determining the presence of multiple mtDNA 
copies in each cell. It has recently been reported 
that epigenetic modifications can occur not only in 
nuclear DNA but also in mtDNA [26].
MtDNA resulted methylated at the D-loop. Both 
5-methylcytosine and 5-hydroxymethylcytosine 
altered content have been reported in disease-
related studies. Indeed, the methylation of mtDNA 
itself, in addition to nuclear DNA methylation, has 
been recently shown to regulate mitochondrial gene 
expression, potentially impacting mitochondrial 
function and leading to diseases [27].
Janssen et al. in 2015 found a positive 
association between mtDNA methylation and 
airborne particulate matter exposure in the early 
life development. In addition, newborns who 
showed a lower mtDNA content in placental tissue 
presented higher levels of mtDNA methylation. 
According to the authors, the lower mtDNA 
content might be related to an increased mitophagy 
and mitochondrial death [28].
The different sets of DNA exist and can vary 
according to biogenesis processes; these copies 
are identical in the first phases. During aging, 
mutations become more numerous and, with 
epigenetics mechanisms, can also be substituted or 
deleted. 
Not all the cells of our body contain the same 
number of mitochondria and of mtDNA copies, 
which also differs among people; thus some people 
may have a reduced mitochondrial efficiency [29]. 
In this perspective, it has been shown that old 
women who have a reduced number of mtDNA 
copies show impaired cognitive abilities [30]. 
In humans, the mtDNA copy number varies 
between 200 and 10,000 in the somatic cells to 
100,000 and 200,000 in oocytes [26]. A human 
somatic cell contains on average about 1,000-
2,000 mitochondria; however, this number can 
vary according to the cellular energetic metabolism 
and these organelles can be more abundant to face 
higher energetic needs. Therefore, metabolically 
active cells such as heart muscle cells or hepatic 
cells can reach the number of 5,000 and 2,000 
mitochondria per cell, respectively [31]. 
 
Mitochondrial DNA: almost a Noah’s Ark 
hypothesis?
The mtDNA allows us to reconstruct our 
genealogical trees, moving back to prehistory and 
acting as a black box of human evolution. In 2013, 
two studies published simultaneously showed that 
mtDNA of Eve and nuclear DNA of Adam were 
probably peers. Although Eve would take its name 
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from the Bible, she was not the only female of 
that period, but she was the only who would have 
produced an unbroken line of daughters. 
The Y-chromosome is another example of non-
recombinant DNA; a copy of it is inherited by the 
father and results similar to its copy. Therefore, it 
represents another important tool for the study of 
human history. 
In the last years, two research groups studied the 
mutations’accumulation rate and discovered that 
the last common male ancestor would have lived 
about 125,000-200,000 years ago. Using the same 
technique to study mtDNA they calculated that 
mtDNA of Eve would have lived 99,000-148,000 
years ago. MtDNA would act like the rings of a 
large tree able to show its age [32, 33]. 
According to a recent study, DNA would be a bar 
code since it perfectly defines the species to which it 
belongs. These findings would underline that about 
90% of the species living on earth would have been 
born all together 100,000-200,000 years ago. 
In conclusion, it can be stated that all the creatures 
from the primitive marsupials up to the evolved 
Homo Sapiens would be contemporaries [34].
Mitochondrial localization and morphology 
through human development
Each egg cell contains about 10,000 
mitochondria; on the contrary, a sperm cell owns 
only a few dozens of them; other body cells contain 
an average of 300-400 mitochondria [35].
In oocytes, mitochondria are spherical with 
small cristae, and they are clustered around the 
nucleus [36]. After the fertilization, mitochondria 
split around the two pronuclei. The perinuclear 
position is probably necessary to face the increased 
energy needs [37].
Human embryonic SCs differ from mature cells 
because their metabolism depends on glycolysis. 
Since they own scarce mitochondria with 
underdeveloped cristae, their oxidative capacity is 
very restricted [38].
During the embryonic development, mito-
chon dria become elongated, filamentous with 
many traverse cristae and move to a peripheric 
location. The mitochondrial networks increase as 
the human embryonic SCs differentiate, because 
their metabolism shifts toward the oxidative 
phosphorylation. It is possible to find a perinuclear 
localization of mitochondria in highly proliferative 
cells types, including other kinds of SCs and cancer 
cells [39].
This is why mitochondria are our destiny
Disproved the previous belief regarding the 
casual distribution of mitochondria into the 
daughter cell, at the moment of each cellular 
division, it has been demonstrated that this 
process can occur with well defined and codified 
rules. This can be observed especially in SCs’ 
asymmetric division, where an asymmetric 
distribution of old and young mitochondria has 
been described. Extraordinarily, the most recently 
synthesized mitochondria are transferred to the 
SC-like daughter, which is destined to survive 
longer, maintaining stemness and undergoing 
numerous replications. On the contrary, old 
mitochondria become constituents of the tissue-
progenitor daughters; these, containing older 
mitochondria, lose their stemness and undergo 
differentiation [40]. Finally, mitochondria may 
also influence SCs aging, since asymmetric 
division can generate a third kind of cell, which 
receives dysfunctional mitochondria and therefore 
undergoes a premature commitment [41]. 
Mitochondria among mother and son
The mitochondrial role has been recently 
evaluated also in the fetal period, finding interesting 
results which provide relevant information 
about maternal-fetal dyad, both in physiological 
and in pathological conditions. The content of 
mitochondria in the placenta also showed a key 
role in several conditions.
For example, many studies have shown that an 
adverse intrauterine environment characterized 
by oxygen and nutrient restriction, increased 
oxidative stress and inflammation, can induce 
and sustain mitochondrial biogenesis. Therefore, 
mitochondrial content results increased in fetal 
blood and placental tissue of intrauterine growth 
restriction (IUGR) and preeclamptic pregnancies. 
Altered mitochondrial content and function are 
also reported in gestational diabetes and maternal 
obesity [27, 42-47]. 
In the last years, many authors published similar 
results, reporting altered mitochondrial content, 
epigenetic modifications and impaired functions in 
the feto-placental unit and in mothers undergoing 
pathological pregnancies.
Whether this is a cause or an effect of the 
compromised intrauterine environment still 
remains unsolved, as this seems to represent a 
vicious circle linking mitochondrial alterations, 
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oxidative stress and inflammation within the im-
paired setting of these pregnancies. 
Moreover, mitochondrial dysfunction has 
been related to impaired placentas, which can 
lead to fetal growth complications and long-term 
consequences for the future adult [48-50]. 
In fact, a poor and nutrient-restricted environ-
ment can damage developing organs through 
several ways, and this fetal programming can 
potentially affect the health of the individual 
longlife [51]. One among these mechanisms 
seems to be the reprogramming of mitochondrial 
function, to face the increasing energy needs and 
supply the uteroplacental insufficiency; therefore, 
a higher production of ROS and an increased 
oxidative stress occur, with systemic and local 
negative effects, especially on tissues such as the 
pancreatic β-cells, hepatocytes, myocytes, and 
placenta itself [51].
Different patterns of methylation have also 
been described in such pathological conditions. 
In particular, a decreased mtDNA methylated 
cytosine content has been found in fetal cord blood 
of pregnancies with IUGR and preeclampsia [27].
Inherited and acquired mitochondrial diseases
Inherited mitochondrial diseases charac-
teristical ly do not affect fetal growth but become 
clinically evident after birth, showing a variable 
spectrum of symptoms mostly characterized by 
organ failure and lactic acidosis. This aspect 
suggests that glycolytic ATP production is 
the essential metabolic pathway during fetal 
development, whereas oxidative phosphorylation 
results more important after birth. Inherited and 
acquired mitochondrial dysfunctions can affect 
any tissue, but brain, liver and heart are the most 
susceptible organs [52].
Forever young
It is widely accepted that mitochondrial dys-
function in aging is related to the accumulation 
of mtDNA mutations and increased ROS produc-
tion. However, the increase in ROS is not the pri-
mary trigger of aging. Currently, some scientists 
have found other mechanisms, since the ROS-
dependent actions are dose-related and not always 
fundamental for the cell. Thus, the new idea of 
mitochondrial “Hormesis” has been proposed, 
introducing the concept that low doses of ROS 
may promote general health and lifespan, while 
higher levels may increase mortality [53]. Many 
other mechanisms, such as altered mitochondrial 
dynamics with an imbalance between fusion and 
fission, defective mitophagy, increased mtDNA 
mutations and reduced ATP levels may lead to 
mitochondrial dysfunction. Alzheimer’s disease 
is the most common neurodegenerative disease; 
it has been demonstrated that the neurons of 
affected patients contain a lower percentage of 
normal mitochondria; moreover, many neural 
cells show fragmented, punctiform or elongated 
mitochondria with a net-like structure or broken 
cristae. Clear mtDNA dysfunction features could 
contribute to Alzheimer’s disease. Mitochondrial 
dysfunction has also been implicated in the 
pathogenesis of Parkinson’s disease. Hence, it has 
also been shown that there are direct or indirect 
interactions between mitochondria and proteins 
encoded by mutated genes even in Mendelian 
Parkinson’s disease [54].
Mitochondria and autism
The current literature suggests a potential 
connection between mitochondrial dysfunction 
and autism and also provides clinical, biochemical 
and genetic evidence to support this association. 
Researchers demonstrated that children affected 
by autism can show three periods of abnormal 
brain development. Thus, their head size is 
generally normal at birth, but generally undergoes 
an overgrowth during infancy and a premature 
growth arrest in childhood; this is followed by a 
shrinking and a degeneration between adolescence 
and middle age, when the brain starts to decrease 
in size. A post-mortem study showed that autistic 
children had about 65% increase of neurons in the 
dorsolateral prefrontal cortex and 25% increase 
of neurons in the medial prefrontal cortex, if 
compared with brains from age-matched control 
patients. The authors hypothesized that a deficit in 
pruning, in association with the overabundance of 
damaged neurons, could cause subsequent faulty 
connection among the different regions of the brain 
[55]. Clinically, the occurrence of macrosomia and 
macrocephaly, occurring in about 20% of autistic 
patients, seems to be more frequent in those with 
underlying mitochondrial diseases. Regarding 
molecular findings, a subgroup of autistic patients 
showed increased levels of plasmatic lactate 
and pyruvate, in addition to organic acids in the 
urine, suggesting a possible defect in oxidative 
phosphorylation processes. Recent evidence, 
7/13
Journal of Pediatric and Neonatal Individualized Medicine • vol. 8 • n. 1 • 2019 www.jpnim.com Open Access
Once we were bacteria… mitochondria to infinity and beyond
obtained from post-mortem studies, points out an 
abnormal mitochondrial function. In the brain of 
autistic children aged between 4 and 10 years, a 
defect in ETC complexes and an increase in the 
mitochondrial copy number have been shown. In 
addition, mtDNA defects occurred in a substantial 
percentage of autistic patients presenting secondary 
mitochondrial dysfunction [56].
Microbiome-mitobiota axis
Recent evidence in metagenomics and clinical 
research suggest that an intriguing bidirectional 
inter-talk may exist between microbiota and 
mitochondria, being able to influence cellular 
homeostasis and metabolism. This connection is 
strengthened by the prokaryotic mitochondrial 
origin [8, 57, 58]. 
Mitochondria and microbiota share two 
important features, since they both have a maternal 
inheritance and a circular genome. In addition, it 
has been shown that patients with mitochondrial 
diseases are more susceptible to develop bacterial 
infections [59].
Recent research underlined the correlation 
between microbiota quality and diversity and 
mitochondrial function [57].
Zorov et al. in 2014 [60] coined the term 
“mitobiota” to highlight the combination of dif-
ferent phenotypic manifestations of mito chon dria, 
which result related to variation in the expression 
of mtDNA. Similarly to what happens to the 
microbiota, biochemical and structural differences 
can be evidenced among mitochondria belonging 
to different cells, organs and even during different 
metabolic cellular states. Moreover, it is also 
possible to find mitochondria with different 
structures, as previously explained, coexisting in 
the same cell [60].
Microbiota could interact with the cells 
promoting the insertion of mtDNA in the nuclear 
DNA sequences [59]. In addition, the gut 
microbiota may produce metabolites that modulate 
mitochondria activity, such as short-chain fatty 
acids, that can activate AMP kinase and lead 
to mitochondrial genesis [58]. Furthermore, in 
worms, mitochondrial dynamics and aging could 
be influenced through the transfer of the bacterial 
polysaccharide colanic acid [61].
Another mechanism applied by gut micro-
biota to influence mitochondrial activity is to 
modify key transcriptional co-activators synthesis, 
tran scription factors and enzymes involved in 
mitochondrial biogenesis, such as peroxisome 
proliferator-activated receptor gamma coactivator 
1-alpha (PGC-1α), sirtuin 1 (SIRT1) and adenosine 
monophosphate-activated protein kinase (AMPK) 
genes. 
Moreover, the gut microbiota and its 
metabolites, such as short-chain fatty acids, bile 
acids, pyrroloquinoline quinone and fermentation 
gases, contribute to host energy production, ROS 
and inflammation modulation [8, 62]. Mito-
chondrial genetic variants, thus, have a crucial 
role in regulating the gut microbiota composition 
and activity, mostly influencing intestinal barrier 
function and mucosal immune responses [8]. 
According to these data, the microbiota targets 
mitochondria influencing their interaction with the 
host and the deregulation of these mechanisms 
could lead to several pathologies [57].
Since it is well known that dietary habits highly 
affect the composition of the gut microbiota and 
that microbial communities have a prominent 
role in the extraction of calories from otherwise 
indigestible food, studies evaluating gut microbiota 
and possible dietary modifications could be useful 
to influence mitochondria-related ROS production, 
pro-inflammatory signals and metabolic patterns 
improving gut health and even endurance in 
athletes [8].
In fact, due to the possibility that bacterial 
species can trigger insertion of bacterial DNA or 
mtDNA in the host genome and induce mutation 
of the somatic cell, the microbiota becomes 
an interesting target to affect intestinal ROS, 
inflammation and other metabolic pathways. Up 
to now, probiotics administration, diet and fecal 
transplantation are promising strategies to shape 
the host microbiota [57].
Evidence suggests that the host genomic 
ancestry may modulate the microbiome. Ma et 
al., taking into account the high mutation rate 
showed by mtDNA and mtSNPs in response 
to several factors (including adaptation to 
thermal conditions and natural selection) and 
the possible link of these sets with different 
human haplogroups, hypothesized that such 
polymorphisms may be associated with variations 
in the human microbiome taxonomic abundance, 
carriage patterns and functional profiling [10]. 
This mechanism has not been fully clarified 
yet, but mtDNA variations could influence 
microbiome through a potential selective and 
different inflammation response to different 
levels of ROS activity [10]. In their study, Ma 
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and colleagues showed significant association 
within several haplogroups between mtDNA sets 
and specific microbiota community. Hirose et al. 
also demonstrated similar findings in mice [63].
It is important to underline that these as-
sociations may potentially have also functional 
and clinical implications. In conclusion, mi-
tochondrial genome can shape the microbiome 
of the host and metagenomics represents a very 
interesting technique to explore such inter ac - 
tions [10].
Mitochondria, immunity and inflammation
Mitochondria play multiple and important 
roles in both innate and adaptive immunity. 
Firstly, mitochondrial ROS are able to digest 
phagocytosed pathogens. Secondly, they may 
activate the most versatile and clinically involved 
cytosolic molecular complex termed NOD-like 
receptor protein (NLRP3)-inflammasome, which 
regulates the production of the inflammatory 
cytokine IL1-β. Moreover, mtDNA is capable 
of amplifying the activation of NLRP3 and to 
activate many innate immune signaling pathways 
acting in the nucleus. Finally, succinate, fumarate 
and citrate (representing some intermediates of 
Krebs’ cycle), are regulators of inflammation and 
result involved in antibacterial host defense [64]. 
Evidence suggests a reciprocal cross-talk 
between mitochondrial fission and fusion 
dynamics and the immune cell metabolism and 
function. Hence, several studies reported that the 
ablation of fission-fusion proteins may damage 
immune cells. Quiescent naive T cells become 
activated by the presence of antigens becoming 
T effector. Most of the T effector cells die, while 
a small number of T memory cells remains in 
a quiescent state. Despite the fact that T cells 
are metabolically characterized by high rates 
of aerobic glycolysis, such condition involves 
mitochondrial function because of the need of 
metabolites generated by the tricarboxylic acid 
cycle to build macromolecules and to change 
the epigenetic prospect. T effector cells are in an 
anabolic state and contain primarily fragmented 
mitochondria. On the contrary, T memory cells 
but also regulatory T cells and alternatively 
ac tivated macrophages rely on catabolic me-
tabolism involving pyruvate or fatty acid oxi-
dative phosphorylation and present hyperfused 
mitochondria. Consequently, mitochondrial me-
tabolic programs seem to dictate the function and 
the fate of immune cells and probably other cell 
types [65].
Mitochondria and cancer
Mitochondrial dysfunction seems to be 
actively involved in tumorigenesis and it has been 
reported in many types of cancers, even if the exact 
relationship still remains unclear. In breast, colon 
and hepatocellular carcinomas, astrocytomas and 
prostate cancers, a low copy number of mtDNA 
has been observed, whereas mutations in mtDNA 
are common in renal adenocarcinoma, thyroid 
tumors, head and neck cancer [66].
As a consequence, cancer cells show an 
impaired oxidative phosphorylation process and a 
less efficient ETC. MtDNA mutations, inducing a 
higher ROS production, activate several pathways 
which result critical for the tumor growth [67].
Both mitochondrial biogenesis and mitophagy 
are essential in cancer initiation, growth, survival 
and metastasization. The modified mitochondrial 
enzymes, due to mtDNA mutations, are involved 
in the production of oncometabolites that could 
trigger tumorigenesis. In addition, an imbalance 
between mitochondrial fission and fusion, together 
with a metabolic reprogramming and an increase 
in oxidative stress signaling are all processes that 
may promote tumor growth. Finally, an impaired 
apoptosis and an alteration in mitochondrial mass 
may even contribute to the survival of cancer 
cells [68, 69]. 
An interesting and innovative therapeutic 
approach has been proposed and evaluated by 
Lamb and colleagues, considering that cancer 
stem cells (CSCs) represent the tumor-initiating 
cells and result indispensable for tumor growth 
and metastasization, independently from the 
tissue giving origin to the tumor itself.
This group, recognizing the need of mi-
tochondrial biogenesis as a weak point in the 
clonal expansion of CSCs, evaluated the efficacy 
of five class of FDA-approved antibiotics (i.e. 
erythromycin, tetracyclines, glycylcyclines, an 
anti-parasitic drug and chloramphenicol) known 
to inhibit mitochondrial biogenesis as a well-
tolerated side-effect, in the treatment of cancer. A 
power in eradicating CSCs in 12 different cancer 
cell lines and across 8 different tumor types has 
been demonstrated, confirming that mitochondrial 
biogenesis is absolutely indispensable for the 
survival and propagation of CSCs. This would 
be an alternative and promising non-toxic anti-
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cancer therapy, although further studies are still 
needed to clarify its implications [70].
To infinity and beyond
A very interesting and promising mitochondrial 
property is the recently demonstrated possibility 
that such organelles can be transferred from a 
donor cell to a recipient cell, providing to this 
recipient several proteins, nucleic acids, ions 
and other small molecules, through a system of 
tunneling nanotubes (TNTs). These are conical 
shaped extensions which can also connect a donor 
mitochondria to a receiver mitochondria [71].
Intercellular communication, among similar or 
different cell types, is a fundamental mechanism 
to promote the homeostasis of tissues and 
organs; it can occur through the sharing of dif-
fusible factors, the secretion of microvesicles or 
the passage of various molecules through gap 
junctions. Moreover, in several cell types and even 
in some bacteria, a long-distance communication 
has also been described, based on a direct cell-to-
cell contact via TNTs, tubular structures mostly 
composed by cytoskeleton, microtubules or actin 
and reaching a length of hundreds of microns 
[72, 73].
This mechanism can involve mitochondrial 
structures, which can be transferred from a cell 
to another, potentially improving the energetic 
metabolism of the targeted cells and modifying 
their functional properties. As reported in Fig. 2, 
in addition to mitochondria, TNTs also allow the 
transfer of Ca2+ ions, lysosomes, vesicles, bacteria, 
and microRNAs.
Up to now, the enormous and enigmatic 
potential of mitochondrial trafficking should 
be deeply defined, especially considering that 
it also seems to occur among cancer cells and 
even connecting these to normal cells or SCs, in 
particular mesenchymal SCs [72].
This could represent a key mechanism to 
provide energy to cancerous cells, promoting their 
survival.
Moreover, many therapeutic applications could 
take advantage of the transfer of mitochondria, 
potentially restoring and sustaining cellular 
metabolism after an ischemic damage. Finally, 
mitochondrial diseases, neurodegenerative and 
neuromuscular disorders, inflammatory damage 
Figure 2. Intercellular trafficking through the tunneling nanotubes (TNTs).
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and even aging are only a few of the fields in 
which future mitochondrial research could induce 
therapeutic steps forwards.
Mitochondrial involvement in the omics science 
revolution
Mitochondrial diseases, currently known as a 
heterogeneous spectrum of disorders characterized 
by variable phenotypic and biochemical presenta-
tion, may be determined by mutations involving 
almost 350 genes of mitochondrial or nuclear 
origin; several mechanisms have been related to 
their occurrence, such as an impaired oxidative 
phosphorylation, the modification of mitochondrial 
ultrastructure, the alteration of metabolic processes 
such as the synthesis of vitamins of cofactors [74].
Due to such variability and the incomplete 
knowledge of all the mitochondria-related 
processes and metabolic pathways, many issues 
about mitochondrial diseases’ pathogenesis, 
manifestations and even reliable therapies are still 
under debate. 
In the last years, the growing interest 
regarding omics sophisticate technologies helped 
to understand more in detail mitochondrial 
pathophysiology, how they may be involved 
in cellular health and disease, also providing 
new strategies for a more accurate diagnosis of 
mitochondrial diseases and new targets for targeted 
therapies [74]. 
For example, although oxidative phosphoryla-
tion structure and function were described several 
years ago, omics sciences recently characterized 
them more in detail; in addition, genome-
wide Clustered Regularly Interspaced Short 
Palindromic Repeats (CRISPR-Cas9) knock-out 
screens allowed the description of interesting 
mitochondrial functions and could reveal new 
therapeutic targets [74, 75].
A transcriptomics approach may suggest 
useful biomarkers of mitochondrial disease and 
quantitative proteomics can be used to investigate 
the deep interactions among mitochondrial 
proteins and their post-translational modifications, 
potentially helping in the identification of new 
genes responsible for mitochondrial disorders.
Moreover, systematic metabolomics studies can 
be useful to analyze on a global scale the metabolic 
consequences of mitochondrial dysfunctions, 
such as the oxidative stress, redox imbalance and 
energy deficiency, leading to the identification of 
biomarkers potentially predictive of the clinical 
outcome and therapeutic targets. Finally, through 
lipidomics, mitochondrial lipid trafficking and 
the diseases related to an impaired in membrane 
homeostasis can be analyzed and characterized.
This really promising integrated approach 
is still in an early stage and further studies will 
be necessary to fully understand the complex 
genotype-phenotype relationships, both regarding 
nuclear and mtDNA, in physiological conditions 
and even highlighting the modifications occurring 
in pathology [74].
Conclusions
Although studies on mitochondria started more 
than a hundred years ago, during the last decades 
a growing interest and the efforts of numerous 
researchers worldwide lead to an improved 
knowledge on this intriguing topic, which 
could constitute our closer and older link with 
prokaryotes and even a connecting bridge towards 
promising future perspectives.
It is now clear that mitochondria are not simple 
organelles providing to energetic metabolism but 
really earned the dignity of dynamic structures in 
constant communication with the cell nucleus itself 
and even, at short- or long-distances, with other 
cells. Thus, they seem to influence metabolism and 
functions of their targets [76].
Since mitochondrial involvement has been 
related to several pathologic conditions and 
degenerative processes, a deeper knowledge 
of their metabolism and of signaling pathways 
regulating mitochondrial transfer, even using 
a combined omics sciences approach, could 
represent a key passage to develop innovative and 
beneficial applications [77].
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